Cargando…

Spanish HTT gene study reveals haplotype and allelic diversity with possible implications for germline expansion dynamics in Huntington disease

We aimed to determine the genetic diversity and molecular characteristics of the Huntington disease (HD) gene (HTT) in Spain. We performed an extended haplotype and exon one deep sequencing analysis of the HTT gene in a nationwide cohort of population-based controls (n = 520) and families with sympt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruiz de Sabando, Ainara, Urrutia Lafuente, Edurne, Galbete, Arkaitz, Ciosi, Marc, García Amigot, Fermín, García Solaesa, Virginia, Monckton, Darren G, Ramos-Arroyo, Maria A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990985/ https://www.ncbi.nlm.nih.gov/pubmed/36130218 http://dx.doi.org/10.1093/hmg/ddac224

Ejemplares similares

Correction to: Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain)
por: de Sabando, Ainara Ruiz, et al.
Publicado: (2019)

Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain)
por: Ruiz de Sabando, Ainara, et al.
Publicado: (2019)

Validation of diagnostic codes and epidemiologic trends of Huntington disease: a population-based study in Navarre, Spain
por: Vicente, Esther, et al.
Publicado: (2021)

HTT haplogroups in Finnish patients with Huntington disease
por: Ylönen, Susanna, et al.
Publicado: (2019)

Approaches to Sequence the HTT CAG Repeat Expansion and Quantify Repeat Length Variation
por: Ciosi, Marc, et al.
Publicado: (2021)

Robust Preimplantation Genetic Testing of Huntington Disease by Combined Triplet-Primed PCR Analysis of the HTT CAG Repeat and Multi-Microsatellite Haplotyping
por: Zhao, Mingjue, et al.
Publicado: (2019)

Parkinsonism with a Hint of Huntington’s from 29 CAG Repeats in HTT
por: JOT, Sipilä
Publicado: (2019)

A probable cis-acting genetic modifier of Huntington disease frequent in individuals with African ancestry
por: Dawson, Jessica, et al.
Publicado: (2022)

Huntington’s Disease—An Outlook on the Interplay of the HTT Protein, Microtubules and Actin Cytoskeletal Components
por: Taran, Aleksandra S., et al.
Publicado: (2020)

In silico designing of putative peptides for targeting pathological protein Htt in Huntington's disease
por: Kohli, Harleen, et al.
Publicado: (2021)

A novel and accurate full-length HTT mouse model for Huntington’s disease
por: Shenoy, Sushila A, et al.
Publicado: (2022)

Alternative processing of human HTT mRNA with implications for Huntington’s disease therapeutics
por: Fienko, Sandra, et al.
Publicado: (2022)

Functional Characterisation of the Circular RNA, circHTT(2-6), in Huntington’s Disease
por: Gantley, Laura, et al.
Publicado: (2023)

FAN1 modifies Huntington’s disease progression by stabilizing the expanded HTT CAG repeat
por: Goold, Robert, et al.
Publicado: (2019)

The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington’s disease patients
por: Neueder, Andreas, et al.
Publicado: (2017)

Epidemiological study and genetic characterization of inherited muscle diseases in a northern Spanish region
por: Pagola-Lorz, Inmaculada, et al.
Publicado: (2019)

Targeting Gpr52 lowers mutant HTT levels and rescues Huntington’s disease-associated phenotypes
por: Song, Haikun, et al.
Publicado: (2018)

Integrated analysis on transcriptome and behaviors defines HTT repeat-dependent network modules in Huntington's disease
por: Huang, Lulin, et al.
Publicado: (2021)

Intrastriatal Administration of AAV5-miHTT in Non-Human Primates and Rats Is Well Tolerated and Results in miHTT Transgene Expression in Key Areas of Huntington Disease Pathology
por: Spronck, Elisabeth A., et al.
Publicado: (2021)

Frequency of the loss of CAA interruption in the HTT CAG tract and implications for Huntington disease in the reduced penetrance range
por: Findlay Black, Hailey, et al.
Publicado: (2020)

An alternative splicing modulator decreases mutant HTT and improves the molecular fingerprint in Huntington’s disease patient neurons
por: Krach, Florian, et al.
Publicado: (2022)

MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1
por: Flower, Michael, et al.
Publicado: (2019)

Developmental Trajectory of Height, Weight, and BMI in Children and Adolescents at Risk for Huntington’s Disease: Effect of mHTT on Growth
por: Tereshchenko, Alexander, et al.
Publicado: (2020)

Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease‐affected families
por: Apolinário, Thays A., et al.
Publicado: (2020)

Htt(Q111/+) Huntington’s Disease Knock-in Mice Exhibit Brain Region-Specific Morphological Changes and Synaptic Dysfunction
por: Kovalenko, Marina, et al.
Publicado: (2018)

Comment on: “Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease‐affected families.”
por: Franklin, Gustavo L., et al.
Publicado: (2020)

Identification of a HTT-specific binding motif in DNAJB1 essential for suppression and disaggregation of HTT
por: Ayala Mariscal, S. M., et al.
Publicado: (2022)

Haplotype-specific insertion-deletion variations for allele-specific targeting in Huntington's disease
por: Shin, Jun Wan, et al.
Publicado: (2022)

AAV5-miHTT Gene Therapy Demonstrates Sustained Huntingtin Lowering and Functional Improvement in Huntington Disease Mouse Models
por: Spronck, Elisabeth A., et al.
Publicado: (2019)

Excess Rab4 rescues synaptic and behavioral dysfunction caused by defective HTT-Rab4 axonal transport in Huntington’s disease
por: White, Joseph A., et al.
Publicado: (2020)

HLA haplotypes associated with hemochromatosis mutations in the Spanish population
por: Pacho, Arantza, et al.
Publicado: (2004)

HTT-DB: new features and updates
por: Dotto, Bruno Reis, et al.
Publicado: (2018)

Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.Htt(Q111/+) model of Huntington’s disease
por: Bragg, Robert M., et al.
Publicado: (2017)

Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6.Htt(Q111/+) mouse model of Huntington’s disease
por: Coffey, Sydney R., et al.
Publicado: (2017)

The Contribution of Somatic Expansion of the CAG Repeat to Symptomatic Development in Huntington’s Disease: A Historical Perspective
por: Monckton, Darren G.
Publicado: (2021)

A Novel Missense Variant Associated with A Splicing Defect in A Myopathic Form of PGK1 Deficiency in The Spanish Population
por: Garcia-Solaesa, Virginia, et al.
Publicado: (2019)

Characterization of HTT Inclusion Size, Location, and Timing in the zQ175 Mouse Model of Huntington´s Disease: An In Vivo High-Content Imaging Study
por: Carty, Nikisha, et al.
Publicado: (2015)

Comparison of mHTT Antibodies in Huntington’s Disease Mouse Models Reveal Specific Binding Profiles and Steady-State Ubiquitin Levels with Disease Development
por: Bayram-Weston, Zubeyde, et al.
Publicado: (2016)

AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington’s disease
por: Miniarikova, J, et al.
Publicado: (2017)

Corrigendum: Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.Htt(Q111/+) model of Huntington’s disease
por: Bragg, Robert M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lite982at9i9d32u4om6lu79kj